Modeling Susceptibility to Cardiotoxicity in Cancer Therapy Using Human iPSC-Derived Cardiac Cells and Systems Biology
Heart Failure Clinics · 2022-07 · 18 (3) · 335-347
DOI: 10.1016/j.hfc.2022.02.009 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Heart Failure Clinics, 2022-07. Verfasst von McKay Mullen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Stanford Cardiovascular Institute, Stanford University, 265 Campus Drive G1120B, Stanford, CA 94304, USA. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Institutes of Health, American Heart Association.
Abstract (Originalsprache)
The development of human-induced pluripotent stem cell-derived cardiac cell types has created a new paradigm in assessing drug-induced cardiotoxicity. Advances in genomics and epigenomics have also implicated several genomic loci and biological pathways that may contribute to susceptibility to cancer therapies. In this review, we first provide a brief overview of the cardiotoxicity associated with chemotherapy. We then provide a detailed summary of systems biology approaches being applied to elucidate potential molecular mechanisms involved in cardiotoxicity. Finally, we discuss combining systems biology approaches with iPSC technology to help discover molecular mechanisms associated with cardiotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stanford Cardiovascular Institute, Stanford University, 265 Campus Drive G1120B, Stanford, CA 94304, USA.
- Department of Medicine, City of Hope Comprehensive Cancer Center, 1500 E Duarte Rd, Duarte, CA 91010, USA. Electronic address: jwrhee@stanford.edu.
- Stanford Cardiovascular Institute, Stanford University, 265 Campus Drive G1120B, Stanford, CA 94304, USA; Department of Medicine, Division of Cardiovascular Medicine, Stanford University; Department of Radiology, Stanfo…
Förderung
- NHLBI NIH HHS
- National Institutes of Health
- American Heart Association
Zitieren
APA
Mullen, M., Wen Tan, W. L., Rhee, J. W., & Wu, J. C. (2022). Modeling Susceptibility to Cardiotoxicity in Cancer Therapy Using Human iPSC-Derived Cardiac Cells and Systems Biology. Heart Failure Clinics, 18(3), 335-347. https://doi.org/10.1016/j.hfc.2022.02.009
Vancouver
Mullen M, Wen Tan WL, Rhee JW, Wu JC. Modeling Susceptibility to Cardiotoxicity in Cancer Therapy Using Human iPSC-Derived Cardiac Cells and Systems Biology. Heart Failure Clinics. 2022;18(3):335-347. doi:10.1016/j.hfc.2022.02.009
BibTeX
@article{Mullen2022,
author = {Mullen, McKay and Wen Tan, Wilson Lek and Rhee, June-Wha and Wu, Joseph C},
title = {Modeling Susceptibility to Cardiotoxicity in Cancer Therapy Using Human iPSC-Derived Cardiac Cells and Systems Biology},
journal = {Heart Failure Clinics},
year = {2022},
volume = {18},
number = {3},
pages = {335--347},
doi = {10.1016/j.hfc.2022.02.009}
}
EUVIMED